C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

Korea Hydro & Nuclear Power has signed an agreement with South Korean construction firm Samsung C&T to establish a strategic ...

Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung ...

Samsung C&T wins iF Design Award for upcycled Raemian goods Samsung C&Ts innovative products showcase creative reuse in ...

Chinese energy storage solutions provider Hithium has entered a strategic global partnership with Samsung C&T Engineering & Construction Group to capitalise on the growing demand for energy ...

Adapture Renewables, Inc., a utility-scale solar and energy storage project developer, owner and operator, announced today ...

The project is strategically placed to address the varied energy requirements of the state's increasing demand.

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

US developer Adapture Renewables has acquired a project from Samsung C&T Renewables, which consists of a 110MW solar project ...